Carvone enhancement of transdermal drug delivery

Details Carvone enhancement of transdermal drug delivery Carvone enhancement of transdermal drug delivery

1987-01-16

1989-12-19

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ketone doai

514772, 514945, 514946, A61K 3112, A61K 4700

Patent

active

048883603

ABSTRACT:
Disclosed herein are compositions and methods for enhancing the transdermal delivery of physiologically active agents across mammalian skin or membranes and which comprise a percutaneous transfer enhancing amount of 1-carvone and a drug.

REFERENCES:
patent: 3551554 (1970-12-01), Herchler
patent: 3896238 (1975-07-01), Smith
patent: 3952099 (1976-04-01), Smith
patent: 3989816 (1976-11-01), Rajadhyaksha
patent: 4046886 (1977-09-01), Smith
patent: 4316893 (1976-11-01), Rajadhyaksha
patent: 4405616 (1983-09-01), Rajadhyaksha
patent: 4465662 (1984-08-01), Sato et al.

Affiliated with

Also associated with

Rating

Carvone enhancement of transdermal drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carvone enhancement of transdermal drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carvone enhancement of transdermal drug delivery will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1903219